CoChat

Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation

Open access
Nakayama, M, Sakai, E, Echizen, K, Yamada, Y, Oshima, H, Han, T-S, Ohki, R, Fujii, S, Ochiai, A, Robine, S, Voon, D C, Tanaka, T, Taketo, M M, Oshima, M · 2017 · Oncogene
Cited by 72

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Tumor suppressor TP53 is frequently mutated in colorectal cancer (CRC), and most mutations are missense type. Although gain-of-functions by mutant p53 have been demonstrated experimentally, the precise mechanism for malignant progression in in vivo tumors remains unsolved. We generated Apc Δ716 Trp53 LSL•R270H villin-CreER compound mice, in which mutant p53 R270H was expressed in the intestinal epithelia upon tamoxifen treatment, and examined the intestinal tumor phenotypes and tumor-derived organoids. Mutant Trp53 R270H , but not Trp53 -null mutation accelerated submucosal invasion with generation of desmoplastic microenvironment. The nuclear accumulation of p53 was evident in Apc Δ716 Trp53 R270H/R270H homozygous tumors like human CRC. Although p53 was distributed to the cytoplasm in Apc Δ716 Trp53 +/R270H heterozygous tumors, it accumulated in the nuclei at the invasion front, suggesting a regulation mechanism for p53 localization by the microenvironment. Importantly, mutant p53 induced drastic morphological changes in the tumor organoids to complex glandular structures, which was associated with the acquisition of invasiveness. Consistently, the branching scores of human CRC that carry TP53 mutations at codon 273 significantly increased in comparison with those of TP53 wild-type tumors. Moreover, allografted Apc Δ716 Trp53 R270H/R270H organoid tumors showed a malignant histology with an increased number of myofibroblasts in the stroma. These results indicate that nuclear-accumulated mutant p53 R270H induces malignant progression of intestinal tumors through complex tumor gland formation and acquisition of invasiveness. Furthermore, RNA sequencing analyses revealed global gene upregulation by mutant p53 R270H , which was associated with the activation of inflammatory and innate immune pathways. Accordingly, it is possible that mutant p53 R270H induces CRC progression, not only by a cell intrinsic mechanism, but also by the generation or activation of the microenvironment, which may synergistically contribute to the acceleration of submucosal invasion. Therefore, the present study indicates that nuclear-accumulated mutant p53 R270H is a potential therapeutic target for the treatment of advanced CRCs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/onc.2017.194

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

Metadata

Authors
Nakayama, M., Sakai, E., Echizen, K., Yamada, Y., Oshima, H., Han, T.-S., Ohki, R., Fujii, S., Ochiai, A., Robine, S., Voon, D. C., Tanaka, T., Taketo, M. M., & Oshima, M.
Venue
Oncogene
Published
2017-06-19
Volume
36
Issue
42
Pages
5885-5896
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2675321527
Cited by
72
References
11
FWCI
2.37
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.